Industries
Healthcare AI & Precision Medicine
All research in Healthcare AI & Precision Medicine — 2 reports.
AI in Healthcare and Life Sciences: A Deep Dive on Commercialization
The largest profit pool in AI healthcare sits not at the model layer but at the clinical-workflow entry point, the billable care episode, regulatory compliance, and the high-quality data loop—a layer Epic, Microsoft Dragon Copilot, and Veeva Vault Agents already occupy. The fastest and most certain commercialization is in clinical voice documentation and workflow automation: Microsoft DAX assisted more than 3 million conversations last month across 600 institutions, and Oracle Clinical AI Agent cut physician documentation time by roughly 30% per day. The FDA has authorized over 1,200 AI-enabled devices, yet high-risk diagnostic and therapeutic AI remains tightly regulated. Precision diagnostics and multi-omics form a clear profit pool: Tempus posted 2025 revenue of $1.27 billion (Data Apps $316.4 million, +30.9%), Guardant Shield secured CMS ADLT pricing, Heartflow generated 2025 revenue of $176 million at a 76.8% gross margin, and iRhythm Zio booked Q1 2025 revenue of $158.7 million at a 68.8% gross margin. The most overrated bets: general-purpose medical Agents, autonomous diagnosis, and the idea that AI immediately throws off blockbuster cash flow. Rating Watch: a structurally attractive but slow-validating sector—key names to track are Tempus / Veeva / Microsoft / Epic / Heartflow / iRhythm / Guardant / Exact Sciences / Viz.ai / Aidoc / Recursion / Schrödinger.
45/100
Tempus AI: A Long-Term Owner's Perspective
A real business with real customers and real growth, but still paying for "future success": 2025 revenue of $1.272 billion (+83%), NRR of about 126%, and Remaining TCV above $1.1 billion, yet operating cash flow was still a net outflow of $218 million and free cash flow stayed negative. What the current $43.93 price lacks is certainty, not story: the valuation prices in near-optimistic assumptions. Rating: Watch, with a more attractive entry range of $18–28.